SM-020 gel 1.0%

DRUG2 trials

Sponsors

DermBiont, Inc.

Conditions

Dermatosis Papulosa NigraSeborrheic Keratosis

Phase 2

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)

Active, not recruitingNCT06099080

DermBiont, Inc.Dermatosis Papulosa Nigra

Start: 2023-11-07End: 2024-07-25Target: 10Updated: 2024-05-01

A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis

RecruitingNCT06108024

DermBiont, Inc.Seborrheic Keratosis

Start: 2023-11-06End: 2024-10-15Target: 60Updated: 2024-05-10